HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis.

Abstract
Aberrant activation of fibroblasts with progressive deposition of extracellular matrix is a key feature of systemic sclerosis (SSc), a prototypical idiopathic fibrotic disease. Here, we demonstrate that the profibrotic cytokine transforming growth factor β selectively up-regulates fibroblast growth factor receptor 3 (FGFR3) and its ligand FGF9 to promote fibroblast activation and tissue fibrosis, leading to a prominent FGFR3 signature in the SSc skin. Transcriptome profiling, in silico analysis and functional experiments revealed that FGFR3 induces multiple profibrotic pathways including endothelin, interleukin-4, and connective tissue growth factor signaling mediated by transcription factor CREB (cAMP response element-binding protein). Inhibition of FGFR3 signaling by fibroblast-specific knockout of FGFR3 or FGF9 or pharmacological inhibition of FGFR3 blocked fibroblast activation and attenuated experimental skin fibrosis in mice. These findings characterize FGFR3 as an upstream regulator of a network of profibrotic mediators in SSc and as a potential target for the treatment of fibrosis.
AuthorsDebomita Chakraborty, Honglin Zhu, Astrid Jüngel, Lena Summa, Yi-Nan Li, Alexandru-Emil Matei, Xiang Zhou, Jingang Huang, Thuong Trinh-Minh, Chih-Wei Chen, Robert Lafyatis, Clara Dees, Christina Bergmann, Alina Soare, Hui Luo, Andreas Ramming, Georg Schett, Oliver Distler, Jörg H W Distler
JournalScience translational medicine (Sci Transl Med) Vol. 12 Issue 563 (09 30 2020) ISSN: 1946-6242 [Electronic] United States
PMID32998972 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Chemical References
  • Transforming Growth Factor beta
  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3
Topics
  • Animals
  • Cells, Cultured
  • Fibroblasts (pathology)
  • Fibrosis
  • Mice
  • Receptor, Fibroblast Growth Factor, Type 3 (genetics, metabolism)
  • Scleroderma, Systemic (pathology)
  • Signal Transduction
  • Skin (pathology)
  • Transforming Growth Factor beta

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: